CAPR · Capricor Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Nippon Shinyaku Co Ltd | ▲ Buy | Open Market | 7,090,351 Shares held | 9/20/2024 | View profile |
| Marban Linda CHIEF EXECUTIVE OFFICER | ▼ Sell | Other | 211,104 Shares held | 3/5/2025 | View profile |
| Litvack Frank | ▲ Buy | Option Exercise | 133,776 Shares held | 5/13/2026 | View profile |
| Musket David B | ▲ Buy | Option Exercise | 81,692 Shares held | 8/7/2024 | View profile |
| Manzo Louis | ▼ Sell | Other | 62,147 Shares held | 2/21/2023 | View profile |
| COLLIER EARL M JR | ▲ Buy | Option Exercise | 57,606 Shares held | 2/27/2025 | View profile |
| Krasney Karen EVP, GENERAL COUNSEL | ▼ Sell | Open Market | 30,547 Shares held | 6/25/2026 | View profile |
| DUNBAR GEORGE W JR | ▲ Buy | Option Exercise | 14,306 Shares held | 12/19/2025 | View profile |
| Bergmann Anthony CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 11,223 Shares held | 6/25/2026 | View profile |
| Auwaerter Paul Gisbert | ▲ Buy | Open Market | 5,000 Shares held | 10/6/2023 | View profile |
| Sabar Karimah Es | ▼ Sell | Open Market | 0 Shares held | 4/2/2026 | View profile |
| Avat Xavier CHIEF BUSINESS OFFICER | ▼ Sell | Open Market | 0 Shares held | 4/17/2023 | View profile |
Transaction History
| Krasney Karen | ▲ Buy | Option Exercise | 24,100 | $77K | 6/25/2026 |
| Krasney Karen | ▼ Sell | Open Market | 24,100 | $732K | 6/25/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 24,100 | $77K | 6/25/2026 |
| Bergmann Anthony | ▼ Sell | Open Market | 24,100 | $732K | 6/25/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 400 | $1K | 6/24/2026 |
| Krasney Karen | ▼ Sell | Open Market | 400 | $12K | 6/24/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 400 | $1K | 6/24/2026 |
| Bergmann Anthony | ▼ Sell | Open Market | 400 | $12K | 6/24/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 500 | $2K | 6/22/2026 |
| Krasney Karen | ▼ Sell | Open Market | 500 | $15K | 6/22/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 500 | $2K | 6/22/2026 |
| Bergmann Anthony | ▼ Sell | Open Market | 500 | $15K | 6/22/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 3,000 | $4K | 5/18/2026 |
| Litvack Frank | ▲ Buy | Option Exercise | 3,937 | $5K | 5/13/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 25,000 | $80K | 5/1/2026 |
| Krasney Karen | ▼ Sell | Open Market | 25,000 | $793K | 5/1/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 25,000 | $80K | 5/1/2026 |
| Bergmann Anthony | ▼ Sell | Open Market | 25,000 | $793K | 5/1/2026 |
| Sabar Karimah Es | ▲ Buy | Option Exercise | 7,529 | $24K | 4/2/2026 |
| Sabar Karimah Es | ▼ Sell | Open Market | 7,529 | $241K | 4/2/2026 |
| Sabar Karimah Es | ▲ Buy | Option Exercise | 53,735 | $261K | 4/1/2026 |
| Sabar Karimah Es | ▼ Sell | Open Market | 53,735 | $1.7M | 4/1/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 693 | $963 | 3/31/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 21,488 | $80K | 3/31/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 2,819 | $9K | 3/31/2026 |
| Krasney Karen | ▼ Sell | Open Market | 25,000 | $753K | 3/31/2026 |
| Sabar Karimah Es | ▲ Buy | Option Exercise | 61,265 | $298K | 3/31/2026 |
| Sabar Karimah Es | ▼ Sell | Open Market | 61,265 | $1.8M | 3/31/2026 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 25,000 | $80K | 3/31/2026 |
| Bergmann Anthony | ▼ Sell | Open Market | 25,000 | $753K | 3/31/2026 |
| Krasney Karen | ▲ Buy | Option Exercise | 2,500 | $3K | 12/30/2025 |
| DUNBAR GEORGE W JR | ▲ Buy | Option Exercise | 3,000 | $4K | 12/19/2025 |
| Marban Linda | ▼ Sell | Other | 12,500 | $0 | 3/5/2025 |
| Marban Linda | ▲ Buy | Option Exercise | 25,000 | $35K | 3/3/2025 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 2,500 | $3K | 3/3/2025 |
| Litvack Frank | ▲ Buy | Option Exercise | 25,000 | $35K | 3/3/2025 |
| Litvack Frank | ▼ Sell | Tax Withholding | 2,543 | $35K | 3/3/2025 |
| DUNBAR GEORGE W JR | ▲ Buy | Option Exercise | 750 | $1K | 3/3/2025 |
| COLLIER EARL M JR | ▲ Buy | Option Exercise | 750 | $1K | 2/27/2025 |
| Bergmann Anthony | ▲ Buy | Grant | 3,342 | $0 | 1/2/2025 |
| Krasney Karen | ▲ Buy | Option Exercise | 8,000 | $11K | 12/13/2024 |
| Litvack Frank | ▲ Buy | Option Exercise | 20,391 | $22K | 12/3/2024 |
| Nippon Shinyaku Co Ltd | ▲ Buy | Open Market | 2,798,507 | $15.0M | 9/20/2024 |
| Musket David B | ▲ Buy | Option Exercise | 34,000 | $47K | 8/7/2024 |
| COLLIER EARL M JR | ▲ Buy | Option Exercise | 30,000 | $42K | 4/23/2024 |
| Musket David B | ▲ Buy | Option Exercise | 16,156 | $22K | 4/23/2024 |
| Bergmann Anthony | ▲ Buy | Option Exercise | 2,178 | $3K | 10/23/2023 |
| Musket David B | ▲ Buy | Open Market | 410 | $1K | 10/12/2023 |
| COLLIER EARL M JR | ▲ Buy | Open Market | 10,000 | $28K | 10/10/2023 |
| Musket David B | ▲ Buy | Open Market | 5,083 | $14K | 10/9/2023 |
| Auwaerter Paul Gisbert | ▲ Buy | Open Market | 5,000 | $14K | 10/6/2023 |
| Musket David B | ▲ Buy | Open Market | 2,500 | $7K | 10/4/2023 |
| Litvack Frank | ▲ Buy | Option Exercise | 20,748 | $29K | 8/14/2023 |
| Litvack Frank | ▼ Sell | Tax Withholding | 4,364 | $29K | 8/14/2023 |
| Marban Linda | ▲ Buy | Option Exercise | 20,749 | $29K | 5/12/2023 |
| Avat Xavier | ▼ Sell | Open Market | 14,772 | $949.2M | 4/17/2023 |
| Avat Xavier | ▲ Buy | Option Exercise | 84,791 | $293K | 4/5/2023 |
| Avat Xavier | ▼ Sell | Tax Withholding | 70,019 | $293K | 4/5/2023 |
| Avat Xavier | ▼ Sell | Open Market | 3,000 | $12K | 3/28/2023 |
| Manzo Louis | ▲ Buy | Option Exercise | 1,401 | $2K | 2/21/2023 |
| Manzo Louis | ▼ Sell | Other | 452 | $2K | 2/21/2023 |
| Litvack Frank | ▲ Buy | Option Exercise | 14,027 | $19K | 2/21/2023 |
| Litvack Frank | ▼ Sell | Tax Withholding | 4,524 | $19K | 2/21/2023 |
| DUNBAR GEORGE W JR | ▲ Buy | Option Exercise | 1,401 | $2K | 2/14/2023 |
| COLLIER EARL M JR | ▲ Buy | Option Exercise | 1,401 | $2K | 2/14/2023 |
| Krasney Karen | ▲ Buy | Option Exercise | 18,932 | $26K | 11/3/2022 |
| Avat Xavier | ▲ Buy | Open Market | 1,000 | $4K | 7/6/2022 |
| Musket David B | ▲ Buy | Option Exercise | 10,796 | $15K | 6/30/2022 |
| Avat Xavier | ▲ Buy | Open Market | 1,500 | $6K | 6/29/2022 |
| Musket David B | ▼ Sell | Open Market | 28,215 | $106K | 6/29/2022 |
| Musket David B | ▼ Sell | Open Market | 17,775 | $79K | 6/27/2022 |
| Manzo Louis | ▲ Buy | Option Exercise | 27,904 | $39K | 3/31/2022 |
| Manzo Louis | ▼ Sell | Tax Withholding | 11,309 | $39K | 3/31/2022 |
| DUNBAR GEORGE W JR | ▲ Buy | Option Exercise | 15,455 | $21K | 3/29/2022 |
| DUNBAR GEORGE W JR | ▼ Sell | Tax Withholding | 6,300 | $21K | 3/29/2022 |
| COLLIER EARL M JR | ▲ Buy | Option Exercise | 15,455 | $21K | 3/8/2022 |
| Litvack Frank | ▲ Buy | Option Exercise | 154,543 | $215K | 1/3/2022 |
| Litvack Frank | ▼ Sell | Tax Withholding | 67,552 | $215K | 1/3/2022 |
| Musket David B | ▲ Buy | Option Exercise | 15,455 | $21K | 12/27/2021 |
| Musket David B | ▲ Buy | Option Exercise | 20,391 | $22K | 12/27/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Capricor Therapeutics Sees Fair Value Adjustments on Deramiocel
Analysts have revised their fair value estimates for Capricor Therapeutics following new data on its lead candidate, Deramiocel. These adjustments reflect updated expectations for the drug's potential, which may influence how investors view the company's long-term outlook. The stock currently trades within a wide 52-week range, indicating significant volatility tied to these clinical developments.
Capricor Therapeutics Sees Fair Value Adjustments on Deramiocel. Analysts have revised their fair value estimates for Capricor Therapeutics following new data on its lead candidate, Deramiocel. These adjustments reflect updated expectations for the drug's potential, which may influence how investors view the company's long-term outlook. The stock currently trades within a wide 52-week range, indicating significant volatility tied to these clinical developments.